Payment overview · 2025
General Payments
$289.48
13 reported records · 12 companies
Healthcare provider profile · identity verified
Eric J Storvick, MD
Allopathic & Osteopathic Physicians|Internal Medicine · MANKATO, MN · NPI 1841279833
Verified facts
What the public records show
CMS Open Payments records show Eric J Storvick, MD received $289.48 in general payments during 2025 across 13 reported records.
Travere Therapeutics, Inc. accounted for 28.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 16 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Travere Therapeutics, Inc. | Unresolved — no canonical attribution shown | $83.23 | 28.8% | 2 | 2025 |
| ABIOMED | Unresolved — no canonical attribution shown | $39.87 | 13.8% | 1 | 2025 |
| Electromed, Inc. | Unresolved — no canonical attribution shown | $20.59 | 7.1% | 1 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $20.06 | 6.9% | 1 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $17.21 | 6.0% | 1 | 2025 |
| Actelion Pharmaceuticals US, Inc. | Unresolved — no canonical attribution shown | $16.26 | 5.6% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $15.94 | 5.5% | 1 | 2025 |
| Soleno Therapeutics, Inc. | Unresolved — no canonical attribution shown | $15.70 | 5.4% | 1 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $15.62 | 5.4% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $15.57 | 5.4% | 1 | 2025 |
| Collegium Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $15.01 | 5.2% | 1 | 2025 |
| Surgenex LLC | Unresolved — no canonical attribution shown | $14.42 | 5.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $289.48 | 13 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SMARTVEST Normalized: smartvest |
Device | Electromed, Inc. | $20.59 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $20.06 | 1 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.21 | 1 | 2025 |
Source payment records
|
|||||
| OPSUMIT Normalized: opsumit |
Drug | Actelion Pharmaceuticals US, Inc. | $16.26 | 1 | 2025 |
Source payment records
|
|||||
| UPTRAVI Normalized: uptravi |
Drug | Actelion Pharmaceuticals US, Inc. | $16.26 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $15.94 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $15.94 | 1 | 2025 |
Source payment records
|
|||||
| VYKAT XR Normalized: vykat xr |
Drug | Soleno Therapeutics, Inc. | $15.70 | 1 | 2025 |
Source payment records
|
|||||
| ZENPEP Normalized: zenpep |
Drug | Aimmune Therapeutics, Inc. | $15.62 | 1 | 2025 |
Source payment records
|
|||||
| NUCALA Normalized: nucala |
Biological | GlaxoSmithKline, LLC. | $15.57 | 1 | 2025 |
Source payment records
|
|||||
| Belbuca Normalized: belbuca |
Drug | Collegium Pharmaceutical, Inc. | $15.01 | 1 | 2025 |
Source payment records
|
|||||
| ArdeoGraft Normalized: ardeograft |
Biological | Surgenex LLC | $14.42 | 1 | 2025 |
Source payment records
|
|||||
| PelloGraft Normalized: pellograft |
Biological | Surgenex LLC | $14.42 | 1 | 2025 |
Source payment records
|
|||||
| RenoGraft Normalized: renograft |
Biological | Surgenex LLC | $14.42 | 1 | 2025 |
Source payment records
|
|||||
| SurGraft Normalized: surgraft |
Biological | Surgenex LLC | $14.42 | 1 | 2025 |
Source payment records
|
|||||
| SurMatrix Normalized: surmatrix |
Biological | Surgenex LLC | $14.42 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 536 | 164 |
| Levothyroxine Sodium | Levothyroxine Sodium | 466 | 111 |
| Losartan Potassium | Losartan Potassium | 430 | 126 |
| Simvastatin | Simvastatin | 429 | 121 |
| Omeprazole | Omeprazole | 419 | 116 |
| Amlodipine Besylate | Amlodipine Besylate | 403 | 124 |
| Metformin Hcl Er | Metformin Hcl | 362 | 104 |
| Gabapentin | Gabapentin | 333 | 108 |
| Lisinopril | Lisinopril | 317 | 94 |
| Torsemide | Torsemide | 308 | 87 |
| Pantoprazole Sodium | Pantoprazole Sodium | 298 | 87 |
| Oxycodone Hcl | Oxycodone Hcl | 292 | 47 |
| Pravastatin Sodium | Pravastatin Sodium | 248 | 61 |
| Metoprolol Succinate | Metoprolol Succinate | 243 | 76 |
| Glimepiride | Glimepiride | 228 | 55 |
| Warfarin Sodium | Warfarin Sodium | 206 | 56 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 204 | 43 |
| Carvedilol | Carvedilol | 181 | 58 |
| Alprazolam | Alprazolam | 175 | 39 |
| Tamsulosin Hcl | Tamsulosin Hcl | 173 | 51 |
| Allopurinol | Allopurinol | 168 | 47 |
| Prednisone | Prednisone | 162 | 64 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 157 | 47 |
| Sertraline Hcl | Sertraline Hcl | 151 | 48 |
| Tramadol Hcl | Tramadol Hcl | 147 | 30 |
| Trazodone Hcl | Trazodone Hcl | 147 | 43 |
| Clonazepam | Clonazepam | 143 | 22 |
| Furosemide | Furosemide | 142 | 49 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 136 | 19 |
| Metformin Hcl | Metformin Hcl | 135 | 39 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 133 | 36 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 130 | 35 |
| Metoprolol Tartrate | Metoprolol Tartrate | 126 | 30 |
| Pioglitazone Hcl | Pioglitazone Hcl | 122 | 32 |
| Quetiapine Fumarate | Quetiapine Fumarate | 122 | 33 |
| Eliquis | Apixaban | 118 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 107 | 33 |
| Memantine Hcl | Memantine Hcl | 100 | 21 |
| Potassium Chloride | Potassium Chloride | 100 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 98 | 31 |
| Ozempic | Semaglutide | 92 | 19 |
| Famotidine | Famotidine | 91 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 90 | 36 |
| Bupropion Xl | Bupropion Hcl | 90 | 23 |
| Atenolol | Atenolol | 88 | 23 |
| Donepezil Hcl | Donepezil Hcl | 88 | 22 |
| Hydrochlorothiazide | Hydrochlorothiazide | 86 | 26 |
| Fluticasone Propionate | Fluticasone Propionate | 83 | 35 |
| Citalopram Hbr | Citalopram Hydrobromide | 82 | 20 |
| Duloxetine Hcl | Duloxetine Hcl | 82 | 21 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 80 | 24 |
| Meloxicam | Meloxicam | 79 | 25 |
| Spironolactone | Spironolactone | 76 | 19 |
| Sucralfate | Sucralfate | 72 | 20 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 69 | 38 |
| Zolpidem Tartrate | Zolpidem Tartrate | 69 | 19 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 67 | 17 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 65 | 41 |
| Fentanyl | Fentanyl | 64 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 64 | 18 |
| Gemfibrozil | Gemfibrozil | 62 | 19 |
| Cephalexin | Cephalexin | 57 | 28 |
| Meclizine Hcl | Meclizine Hcl | 57 | 15 |
| Humalog Kwikpen U-100 | Insulin Lispro | 56 | 18 |
| Lorazepam | Lorazepam | 56 | 15 |
| Nabumetone | Nabumetone | 53 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 52 | 14 |
| Diazepam | Diazepam | 51 | suppressed |
| Lovastatin | Lovastatin | 46 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 45 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 45 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 45 | 11 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 44 | suppressed |
| Glipizide Er | Glipizide | 44 | suppressed |
| Mirtazapine | Mirtazapine | 43 | 14 |
| Mounjaro | Tirzepatide | 43 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 43 | suppressed |
| Estradiol | Estradiol | 42 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 42 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 41 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 40 | 29 |
| Valsartan | Valsartan | 40 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 39 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 38 | suppressed |
| Metronidazole | Metronidazole | 37 | 27 |
| Bupropion Hcl Sr | Bupropion Hcl | 36 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 36 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 35 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 35 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 34 | 12 |
| Jardiance | Empagliflozin | 34 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 34 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 33 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 32 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 32 | suppressed |
| Eszopiclone | Eszopiclone | 32 | suppressed |
| Synthroid | Levothyroxine Sodium | 32 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 31 | suppressed |
| Levetiracetam | Levetiracetam | 31 | suppressed |
| Novolog Flexpen | Insulin Aspart | 31 | 12 |
| Amoxicillin | Amoxicillin | 30 | 21 |
| Propranolol Hcl Er | Propranolol Hcl | 30 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 29 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 29 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 28 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 27 | suppressed |
| Xarelto | Rivaroxaban | 27 | suppressed |
| Celecoxib | Celecoxib | 26 | suppressed |
| Naproxen | Naproxen | 26 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 26 | 12 |
| Finasteride | Finasteride | 25 | suppressed |
| Klor-Con M20 | Potassium Chloride | 25 | suppressed |
| Pregabalin | Pregabalin | 25 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 25 | suppressed |
| Trulicity | Dulaglutide | 25 | suppressed |
| Belsomra | Suvorexant | 24 | suppressed |
| Cefdinir | Cefdinir | 24 | 19 |
| Fenofibrate | Fenofibrate Nanocrystallized | 24 | suppressed |
| Methocarbamol | Methocarbamol | 24 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 24 | suppressed |
| Ezetimibe | Ezetimibe | 23 | 11 |
| Methadone Hcl | Methadone Hcl | 23 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 23 | 23 |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 23 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 22 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 22 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Temazepam | Temazepam | 22 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 22 | 14 |
| Fenofibrate | Fenofibrate | 21 | suppressed |
| Lamotrigine | Lamotrigine | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | 17 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 21 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Baclofen | Baclofen | 20 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Glipizide | Glipizide | 20 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 20 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 19 | suppressed |
| Hydrocortisone | Hydrocortisone | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Aripiprazole | Aripiprazole | 18 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 18 | suppressed |
| Ursodiol | Ursodiol | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Azathioprine | Azathioprine | 17 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Budesonide Dr | Budesonide | 16 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 16 | suppressed |
| Bumetanide | Bumetanide | 15 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 15 | suppressed |
| Creon | Lipase/Protease/Amylase | 15 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 15 | suppressed |
| Januvia | Sitagliptin Phosphate | 15 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | 12 |
| Loperamide | Loperamide Hcl | 14 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 14 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 14 | suppressed |
| Azithromycin | Azithromycin | 13 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 13 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 13 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Novolog | Insulin Aspart | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Rybelsus | Semaglutide | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Praluent Pen | Alirocumab | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 11 | suppressed |
| Nystatin | Nystatin | 11 | suppressed |
| Oxycontin | Oxycodone Hcl | 11 | suppressed |
| Ranolazine Er | Ranolazine | 11 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $289.48 · 13 records | Travere Therapeutics, Inc. | ArdeoGraft, Belbuca, CAPLYTA, NUCALA, OPSUMIT, OTEZLA, PelloGraft, REPATHA, RenoGraft, SMARTVEST, SurGraft, SurMatrix, UPTRAVI, VOQUEZNA, VYKAT XR, ZENPEP | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error